Abstract
Until recently little advance in the diagnosis and excision of breast cancer has been made since the inception of needle localization breast biopsy (NLBB). Stereotactic core needle breast biopsy (SCNBB) can avoid most NLBB especially for calcifications. However, when open biopsy is necessary NLBB has been the standard of care. As many as 50 per cent of nonpalpable lesions can be seen by ultrasound (US) to avoid the unpleasantness and complications associated with NLBB. Further SCNBB leaves a blood-filled cavity that can be easily seen by US. Intraoperative US can be used to direct the excision while improving margin negativity. MRI has improved sensitivity in detecting suspicious breast lesions and techniques such as hematoma-directed US-guided breast biopsy can facilitate excision of such masses. Clearly new technologies have improved the ability to diagnosis and excise breast cancer. The onus on the surgeon is to incorporate them into standard practice to improve outcomes.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 11-14 |
| Number of pages | 4 |
| Journal | American Surgeon |
| Volume | 69 |
| Issue number | 1 |
| State | Published - 2003 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Surgery
- Medicine(all)
Cite this
Advances in the diagnosis and excision of breast cancer. / Klimberg, Vicki.
In: American Surgeon, Vol. 69, No. 1, 2003, p. 11-14.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Advances in the diagnosis and excision of breast cancer
AU - Klimberg, Vicki
PY - 2003
Y1 - 2003
N2 - Until recently little advance in the diagnosis and excision of breast cancer has been made since the inception of needle localization breast biopsy (NLBB). Stereotactic core needle breast biopsy (SCNBB) can avoid most NLBB especially for calcifications. However, when open biopsy is necessary NLBB has been the standard of care. As many as 50 per cent of nonpalpable lesions can be seen by ultrasound (US) to avoid the unpleasantness and complications associated with NLBB. Further SCNBB leaves a blood-filled cavity that can be easily seen by US. Intraoperative US can be used to direct the excision while improving margin negativity. MRI has improved sensitivity in detecting suspicious breast lesions and techniques such as hematoma-directed US-guided breast biopsy can facilitate excision of such masses. Clearly new technologies have improved the ability to diagnosis and excise breast cancer. The onus on the surgeon is to incorporate them into standard practice to improve outcomes.
AB - Until recently little advance in the diagnosis and excision of breast cancer has been made since the inception of needle localization breast biopsy (NLBB). Stereotactic core needle breast biopsy (SCNBB) can avoid most NLBB especially for calcifications. However, when open biopsy is necessary NLBB has been the standard of care. As many as 50 per cent of nonpalpable lesions can be seen by ultrasound (US) to avoid the unpleasantness and complications associated with NLBB. Further SCNBB leaves a blood-filled cavity that can be easily seen by US. Intraoperative US can be used to direct the excision while improving margin negativity. MRI has improved sensitivity in detecting suspicious breast lesions and techniques such as hematoma-directed US-guided breast biopsy can facilitate excision of such masses. Clearly new technologies have improved the ability to diagnosis and excise breast cancer. The onus on the surgeon is to incorporate them into standard practice to improve outcomes.
UR - http://www.scopus.com/inward/record.url?scp=0037268323&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037268323&partnerID=8YFLogxK
M3 - Article
C2 - 12575773
AN - SCOPUS:0037268323
VL - 69
SP - 11
EP - 14
JO - The American surgeon
JF - The American surgeon
SN - 0003-1348
IS - 1
ER -